Journals / Haydarpaşa Numune Medical Journal / 2022 / Cilt: 62 - Sayı: 1

Lambda Light Chain Cast Nephropathy: A Case Report

Pages
113–115
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although this condition, called cast nephropathy, is most seen in multiple myeloma, it may also be associated with Waldenström macroglobulinemia and lymphomas.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Excess production of free light chains is due to underlying plasma cell dyscrasia or a lymphoproliferative disease.
📊
Key Findings & Data:When the degradation capacity by proximal tubule is exceeded as a result of overproduction, the excess light chains produced reach the distal tubule and cause accumulation, causing deterioration in kidney functions.
💡
Conclusion & Impact:Although this condition, called cast nephropathy, is most seen in multiple myeloma, it may also be associated with Waldenström macroglobulinemia and lymphomas.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Excess production of free light chains is due to underlying plasma cell dyscrasia or a lymphoproliferative disease. When the degradation capacity by proximal tubule is exceeded as a result of overproduction, the excess light chains produced reach the distal tubule and cause accumulation, causing deterioration in kidney functions. Although this condition, called cast nephropathy, is most seen in multiple myeloma, it may also be associated with Waldenström macroglobulinemia and lymphomas.

🔖

Cite This Article

KOÇ, E. S. (2022). Lambda Light Chain Cast Nephropathy: A Case Report. Haydarpaşa Numune Medical Journal, Cilt: 62 - Sayı: 1, 113–115. https://ajindex.com/articles/535825

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB. Monoclonal gammopathy: Significance and possible causality in renal disease. Am J Kidney Dis 2003;42:87–95
  2. Lorenz EC, Sethi S, Poshusta TL, Ramirez-Alvarado M, Kumar S, Lager DJ, et al. Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease. Nephrol Dial Transplant 2010;25:1340–3
  3. Vos JM, Gustine J, Rennke HG, Hunter Z, Manning RJ, Dubeau TE, et al. Renal disease related to Waldenström macroglobulinaemia: Incidence, pathology and clinical outcomes. Br J Haematol 2016;175:623–30
  4. Burke JR Jr, Flis R, Lasker N, Simenhoff M. Malignant lymphoma with "myeloma kidney" acute renal failure. Am J Med 1976;60:1055–60
  5. Strati P, Nasr SH, Leung N, Hanson CA, Chaffee KG, Schwager SM, et al. Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: The Mayo clinic experience. Haematologica 2015;100:1180–8
  6. Pozzi C, D'Amico M, Fogazzi GB, Curioni S, Ferrario F, Pasquali S, et al. Light chain deposition disease with renal involvement: Clinical characteristics and prognostic factors. Am J Kidney Dis 2003;42:1154–63
  7. Gowda KK, Joshi K, Nada R, Ramachandran R, Sachdeva M. Light chain proximal tubulopathy with cast nephropathy in a case of multiple myeloma. Indian J Nephrol 2015;25:119–22.